Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Re (RMAX) Gains from Sales and Divestitures (2016 - 2025)

Re (RMAX) has disclosed Gains from Sales and Divestitures for 12 consecutive years, with $237463.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 125.74% to $237463.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $237463.0, a 125.74% increase, with the full-year FY2025 number at $237463.0, up 125.74% from a year prior.
  • Gains from Sales and Divestitures was $237463.0 for Q4 2025 at Re, down from $907191.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $907191.0 in Q3 2025 to a low of $24122.0 in Q2 2023.
  • A 5-year average of $376696.0 and a median of $378347.0 in 2024 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 93.52% in 2021, then surged 1481.15% in 2024.
  • Re's Gains from Sales and Divestitures stood at $48421.0 in 2021, then skyrocketed by 281.22% to $184592.0 in 2022, then decreased by 27.35% to $134114.0 in 2023, then fell by 21.56% to $105193.0 in 2024, then surged by 125.74% to $237463.0 in 2025.
  • Per Business Quant, the three most recent readings for RMAX's Gains from Sales and Divestitures are $237463.0 (Q4 2025), $907191.0 (Q3 2025), and $902001.0 (Q2 2025).